Trials / Unknown
UnknownNCT03480178
Renal Anemia Refractory to Erythropoietin
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
This study evaluates the renal anemia refractory to Epo . in hemodialysis patients. all of participants will receive Epo. and identify various factors contributing to etiology of renal anemia in Epo- resistant patients.
Detailed description
Chronic kidney disease (CKD) is considered a public health problem worldwide with high incidence and prevalence rates.Anemia is one of the most frequent early complication of CKD. The main cause is erythropoietin (EPO) deficiency due to impaired kidney function However, other causes should be considered when the severity of anemia is inconsistent with the decrease in renal function; when there is evidence of iron deficiency or matching decreases in hemoglobin, leukopenia and/or thrombocytopenia are also found
Conditions
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2019-01-01
- Completion
- 2019-05-01
- First posted
- 2018-03-29
- Last updated
- 2019-01-02
Source: ClinicalTrials.gov record NCT03480178. Inclusion in this directory is not an endorsement.